Sanofi Pasteur today shipped the first of what will be 70 million doses of vaccine for the winter ahead.
The shipment includes it's regular Fluzone vaccine, as well as a new high-dose vaccine for those 65 and older, who sometimes don't get enough protection from regular doses.
This year, the company also has a newly-approved vaccine that's delivered through a micro-needle, 90 per cent shorter than standard needles. The Fluzone Intradermal vaccine was approved by the Food and Drug Administration in May 2011. It is expected to appeal to a younger poopulation, those 18 and up, an age group which has a lower immunization rate.
Sanofi is the nation's largest flu vaccine maker, making 40 per cent of the nation's supply.
